Potential development candidates emerging from Panacea's HAAH-targeted oncology program Nov. 23, 2001
Gemin X reports in vivo efficacy for small-molecule, cancer-specific apoptosis inducers Nov. 23, 2001
Genzyme Molecular Oncology and Kirin Brewery form human monoclonal antibodies collaboration Nov. 21, 2001
RSS